Document:

Exhibit 10.1

                              CONSULTING AGREEMENT

      This Consulting  Agreement (this  "Agreement") dated April 21, 2005, is by
and between Marvin Feigenbaum,  an individual  residing at 124 West 60th Street,
Apt 33L, New York,  New York  10023(the  "Consultant"),  and United  Diagnostic,
Inc., a Delaware  corporation  with its  executive  offices  located at 3 Gavish
Street, Kfar Saba, Israel (the "Company").

Recitals

      A. The Company  desires to retain the Consultant for the term set forth in
this  Agreement  to assure  itself of the  services of the  Consultant,  and the
Consultant  is willing to be  retained  by the Company for the term on the terms
and conditions set forth below.

      B. The Consultant desires to provide the services under this Agreement and
represents that he is qualified to perform such services.

Agreement

      1.  Retention of the  Consultant.  Subject to the terms and conditions set
forth in this  Agreement,  the Company  hereby retains the Consultant to perform
the  services  set forth in this  Agreement,  and the  Consultant  accepts  this
retention on the terms and conditions set forth in this Agreement.

      2. Term. The term of this  Agreement  shall commence on April 21, 2005 and
continue for one year.  The Company may terminate  this Agreement at any time by
providing 30 days written notice of such intention to the Consultant.

      3.  Scope and  Location  of Work.  The  services  to be  performed  by the
Consultant  under this Agreement (the "Work") shall be to give financial  advice
to the Company..  During the term of this  Agreement,  the Consultant  agrees to
devote not more than 2 days per month to his duties  under this  Agreement.  The
Consultant  shall not be required to travel for any  purpose,  including  travel
near  Consultant's  home or office,  and may  communicate  with the  Company and
others by means of  telephone,  computer,  fax or any other means  chosen by the
Consultant.

      4. Compensation and Payment. In full payment for the Consultant's services
hereunder  the  Company  agrees  to pay  the  Consultant  the  sum  of  $100,000
simultaneously  with the  execution of this  Agreement.  Such  payment  shall be
deemed earned in full upon the  execution of this  Agreement and no part of such
payment shall be refundable for any reason.

(a) No Reverse Stock Split;  D&O  Insurance;  144 Sales.  (i) For a period of 18
months  after the date of this  Agreement,  the Company  will not  consummate  a
reverse stock split without the prior written consent of the Consultant.

(ii) For a period of two  years  after the date of this  Agreement  the  Company
shall cause the  Consultant  to be covered with respect to any acts or omissions
of the  Consultant  during  the term of this  Agreement  under an  officers  and
directors errors and omissions  liability policy  maintained by the Company with
the same insurance  company  covering  officers and directors of the Company and
which  policy  shall  provide  coverage to the  Consultant  to at least the same
extent as  provided to officers  and  directors  of the Company and in any event
have  limits  of at  least  $1,000,000  per  occurrence  and  $2,000,000  in the
aggregate.  In addition,  the Company  shall not amend Article IX of its Amended
and Restated  By-laws (as of July 11, 2000), a copy of which is attached  hereto
as Exhibit A, or amend the  Certificate of  Incorporation  of the Company in any
manner which would  supercede  the  provisions  of Article IX of the Amended and
Restated By-laws of the Company.

(iii) Within 10 days after a request  therefore is made by the Consultant  which
request shall include all documentation  reasonably necessary to evidence either
(A) the  availability of Rule 144 (as reasonably  determined by Company counsel)
or (B) the availability of a "no sale" opinion regarding a gift of shares,  with
respect to the shares  requested to be transferred,  the Company shall cause its
counsel  to issue to the  Company's  transfer  agent a  favorable  opinion  that
Feigenbaum   may  transfer  the  shares   referenced  in  the  request   without
registration  under the Securities Act of 1933, as amended (the "Act") by virtue
of an  exemption  from  registration  afforded  under  Rule 144 or  because  the
registration  provisions  of the Act do not apply  because the transfer is not a
sale,  as defined in the Act, as the case may be. The Company shall also deliver
to its transfer  agent any other  documentation,  if any,  necessary to transfer
such shares.  The Company shall bear all fees and expenses of Company's  counsel
in connection with the foregoing opinions If the Consultant transfers any of his
shares to a donee, the obligations of the Company in this Section  4(a)(iii) may
also be exercised by the donee. As liquidated damages and not as a penalty,  for
every day the Company is in default  under its  obligations  under this  Section
4(a)(iii),  the  Company  shall  issue to the  Consultant  10,000  shares of the
Company's Common stock.(such number of shares to be proportionately  adjusted if
the outstanding shares of the Company shall exceed 6,597,090 shares.

                                                                               1
<PAGE>

(b) Registration Rights. The Company is simultaneously  herewith entering into a
registration  rights  agreement  with the  Consultant  in the form of  Exhibit B
attached hereto.

(c) Expense Reimbursement. The Consultant shall be entitled to reimbursement for
all reasonable  travel  related  expenses upon advance  written  approval of the
Company.

      5. Independent Contractor. The Consultant agrees to perform the Work as an
independent contractor.  The Consultant is not granted any right or authority or
responsibility,  expressed,  implied or apparent, on behalf of or in the name of
the Company to bind, or act on behalf of, the Company.

      6. Modifications.  No amendment or modification to this Agreement shall be
effective unless made in writing.

      7. Assignment.  This Agreement and all of the Consultant's rights,  duties
and  obligations  under this  Agreement  are  personal in nature and,  except as
provided in Section  4(a)(iii) of this  Agreement,  shall not be  subcontracted,
assigned, delegated or otherwise disposed of by the Consultant without the prior
written consent of the Company.

      8. Liability  Limitation.  In no event shall either party be liable to the
other party whether in contract, tort or otherwise,  for payment of any special,
indirect, incidental, consequential or similar damages.

      9. Indemnification.  The Company shall protect, defend, indemnify and hold
the  Consultant  free  and  unharmed  from  and  against  any  and  all  claims,
liabilities, loss, costs, or damages, including court costs and attorneys' fees,
whether  raised  by the  Consultant  or a third  party,  which  shall  arise  in
connection  with  any  breach  by  the  Company  of  a  covenant,   warranty  or
representation contained herein.

      10. Notice.  All notices  required  under this  Agreement  shall be deemed
given when sent by overnight  courier or registered  or certified  mail, or when
sent by telecopy,  telegraph or other graphic, electronic means and confirmed by
overnight  courier or registered or certified  mail addressed to the address set
forth in the  preamble to this  Agreement.  Either party shall have the right to
change  the  address  or  name of the  person  to whom  such  notices  are to be
delivered by notice to the other party.

      11. Law and Venue. This Agreement shall be governed in all respects by and
construed in accordance with the laws of the State of New York without regard to
conflicts  of law  provisions.  Any  litigation  between  the  parties  shall be
conducted in the state of federal courts of the State of New York.

      12.  Waiver  of Trial by  Jury.  The  Company  and the  Consultant  hereby
knowingly, voluntarily and intentionally waive the right to a trial by jury with
respect  to any  litigation  based  hereon,  or  arising  out  of,  under  or in
connection with this agreement.  This provision is a material inducement for the
parties entering into this agreement.

      13. Headings.  The headings in this Agreement are provided for convenience
of  reference  only and shall not  affect the  construction  of the text of this
Agreement.

      14.  Non-Waiver.  No waiver of any  provision of this  Agreement  shall be
deemed to be nor shall  constitute a waiver of any other  provision,  whether or
not similar,  nor shall any waiver  constitute a  continuing  waiver.  No waiver
shall be binding unless executed in writing by the party making the waiver.

      15. Cumulative Remedies. All rights and remedies of the parties under this
Agreement shall be cumulative, and the exercise of any one right or remedy shall
not bar the exercise of any other right or remedy.

      16.  Severability.  If any  provision of this  Agreement  shall be held or
deemed to be invalid, inoperative or unenforceable, such circumstances shall not
affect the validity of any other provision of this Agreement.

      17. Complete  Agreement.  This Agreement  constitutes the entire and final
agreement   and   supersedes   all   prior   and   contemporaneous   agreements,
representations,  warranties and  understandings  of the parties,  whether oral,
written  or  implied.  The  inclusion  of this  provision  has  been a  material
inducement for each of the parties to enter into this Agreement.

                                                                               2
<PAGE>

      The parties have executed this Agreement  effective as of the day and year
      first above written.

United Diagnostic, Inc.                   Consultant

/s/ Michael Braunold                      /s/ Marvin Feigenbaum
--------------------                      ---------------------

Michael Braunold                          Marvin Feigenbaum

                                                                               3
<PAGE>

                                    Exhibit A

       Indemnification Provisions Contained in Article IX of the Company's
                Amended and Rested By-laws (as of July 11, 2000)

                                   ARTICLE IX

                          INDEMNIFICATION OF DIRECTORS,

                             OFFICERS AND EMPLOYEES

      Except to the extent expressly prohibited by the Delaware Corporation Law,
the  corporation  shall  indemnify  each person made or  threatened to be made a
party to any action or proceeding,  whether civil or criminal,  by reason of the
fact that  such  person  or such  person's  testator  or  intestate  is or was a
director,  officer or  employee of the  corporation,  or serves or served at the
request of the corporation, any other corporation,  partnership,  joint venture,
trust,  employee  benefit  plan or other  enterprise  in any  capacity,  against
judgment, fines, penalties,  amounts paid in settlement and reasonable expenses,
including   attorneys'  fees,   incurred  in  connection  with  such  action  or
proceeding,  or any appeal therein,  provided that no such indemnification shall
be made if a  judgment  or  other  final  adjudication  adverse  to such  person
establishes  that his or her acts were committed in bad faith or were the result
of active and deliberate  dishonesty and were material to the cause of action so
adjudicated,  or that he or she personally  gained in fact a financial profit or
other  advantage  to  which he or she was not  legally  entitled,  and  provided
further  that no such  indemnification  shall be  required  with  respect to any
settlement  or other  nonadjudicated  disposition  of any  threatened or pending
action or proceeding  unless the corporation has given its prior consent to such
settlement or other disposition.

      The corporation may advance or promptly  reimburse upon request any person
entitled to  indemnification  hereunder for all expenses,  including  attorneys'
fees,  reasonably  incurred in defending  any action or proceeding in advance of
the final disposition  thereof upon receipt of an undertaking by or on behalf of
such person to repay such amount if such  person is  ultimately  found not to be
entitled to indemnification or, where  indemnification is granted, to the extent
the expenses so advanced or reimbursed exceed the amount to which such person is
entitled, provided, however, that such person shall cooperate in good faith with
any request by the corporation that common counsel be utilized by the parties to
an action or  proceeding  who are  similarly  situated  unless to do so would be
inappropriate  due to actual or potential  differing  interests between or among
such parties.

      Nothing  herein  shall  limit or affect any right of any person  otherwise
than hereunder to indemnification or expenses,  including attorneys' fees, under
any statute, rule, regulation,  certificate of incorporation,  by-law, insurance
policy, contract or otherwise.

      Anything in these by-laws to the contrary notwithstanding,  no elimination
of this by-law, and no amendment of this by-law adversely affecting the right of
any person to  indemnification  or  advancement of expenses  hereunder  shall be
effective until the 60th day following notice to such person or such action, and
no elimination of or amendment to this by-law shall deprive any person of his or
her rights  hereunder  arising  out of alleged  or actual  occurrences,  acts or
failures to act prior to such 60th day.

      The  corporation  shall not,  except by  elimination  or amendment of this
by-law in a manner consistent with the preceding  paragraph,  take any corporate
action or enter into any  agreement  which  prohibits,  or otherwise  limits the
rights of any person to,  indemnification  in accordance  with the provisions of
this by-law.  The  indemnification  of any person  provided by this by-law shall
continue  after such person has ceased to be a director,  officer or employee of
the  corporation  and  shall  inure  to the  benefit  of  such  person's  heirs,
executors, administrators and legal representatives.

      The  corporation  is authorized to enter into  agreements  with any of its
directors,  officers  or  employees  extending  rights  to  indemnification  and
advancement  of  expenses  to such person to the  fullest  extent  permitted  by
applicable  law,  but the  failure  to enter into any such  agreement  shall not
affect or limit the rights of such  person  pursuant  to this  by-law,  it being
expressly  recognized  hereby that all directors,  officers and employees of the
corporation,  by  serving  as such  after the  adoption  hereof,  are  acting in
reliance hereon and that the corporation is estopped to contend otherwise.

      In case any provision in this by-law shall be determined at any time to be
unenforceable  in any  respect,  the  other  provisions  shall not in any way be
affected or impaired  thereby,  and the  affected  provision  shall be given the
fullest possible enforcement in the circumstances, it being the intention of the
corporation  to  afford  indemnification  and  advancement  of  expenses  to its
directors,  officers and  employees,  acting in such  capacities or in the other
capacities mentioned herein, to the fullest extent permitted by law.

                                                                               4
<PAGE>

      For  purposes  of this  by-law,  the  corporation  shall be deemed to have
requested a person to serve an employee  benefit plan where the  performance  by
such person of his or her duties to the corporation  also  beneficiaries  of the
plan, and excise taxes assessed on a person with respect to an employee  benefit
plan pursuant to applicable law shall be considered  indemnifiable expenses. For
purposes  of this  by-law,  the  term  "corporation"  shall  include  any  legal
successor to the  corporation,  including any corporation  which acquires all or
substantially all of the assets of the corporation in one or more transactions.

                                                                               5Exhibit 10.2

-----------------------
Name of Offeree

                                SPO MEDICAL INC.
                         FORM OF SUBSCRIPTION AGREEMENT

SPO Medical  Inc.
Suite 380,
North Building,
21860, Burbank Boulevard,
Woodland Hills,
CA 91367-6493

Attention:  Michael Braunold

Gentlemen:

1.  Subscription.  (a) Subject to the terms and conditions of this Agreement the
undersigned  hereby agrees to loan to SPO Medical  Inc., a Delaware  corporation
(the  "Company"),  the principal  amount set forth on the Purchaser's  signature
page of this Agreement (the "Purchase Price"), out of the aggregate amount being
loaned by all  Purchasers of US  $1,000,000  (the  "Offering").  The Company may
increase the aggregate amount of the Offering by $150,000.

      (b) The obligation to repay the loan from the Purchaser shall be evidenced
by the Company's  issuance of one or more 6% promissory  notes with interest and
principal  repayable at the end of 18 months  ("Note").  In addition the Company
shall  issue to each  Purchaser  a two year  common  stock  purchase  warrant to
purchase  shares  of the  Company  up to the  principal  amount  of the Note and
exercisable  at $0.85  per  share  (the  "Warrant").  The  terms of the Note and
Warrant  (jointly  the  "Unit(s)")  are set forth in Exhibit "A" and "B" to this
Agreement.

      (c) The Purchaser  understands  that this  subscription may be rejected by
the Company at any time in its sole  discretion and that the Company will advise
the Purchaser as soon as practicable  if the  Purchaser's  subscription  has not
been accepted.  If rejected,  all amounts  delivered by the Purchaser as payment
for the Units will be promptly  returned  to the  Purchaser  and this  Agreement
shall have no further force or effect  (except for the  provisions of Section 14
hereof).  If the Purchaser's  subscription is rejected,  the Purchaser agrees to
return to the Company any  documents  the Company has provided to the  Purchaser
for the purpose of evaluating  its investment in the Units.  If the  Purchaser's
subscription is accepted, the Company will promptly provide the Purchaser with a
Note and Warrant that constitute the Units purchased.

2. Payment.  Upon  execution of this  Agreement,  the Purchaser will pay by bank
check or wire  transfer the full amount of the  purchase  price of the Units for
which the  Purchaser  is  subscribing  pursuant to the terms of this  Agreement.
Money shall be sent to the escrow agent as follows. If by wire:

Bank of America
Address: 260 Canal Street
New York, New York
Account #: 2163015671
ABA #: 021200339
Swift Code: FNBBUS33
Account Beneficiary: Lawrence Katz
Reference: SPO Medical Inc.

Or by check to: Lawrence Katz as Attorney

                                                                               1
<PAGE>

3.  Representations,  Warranties and Covenants of the  Purchaser.  The Purchaser
hereby  acknowledges  that his investment in the Units involves a high degree of
risk and his economic  circumstances are such that he can afford the loss of his
investment. The Purchaser further acknowledges,  represents, warrants and agrees
as follows:

      (a) The Purchaser is an "accredited investor" as defined by Rule 501 under
the Securities Act of 1933, as amended (the "Act"), and the Purchaser is capable
of evaluating the merits and risks of Subscriber's investment in the Company and
has the capacity to protect the Purchaser's  own interests.  The Purchaser meets
the requirements of at least one of the suitability standards for an "accredited
investor"  as set  forth  on the  Accredited  Investor  Certification  contained
herein;

      (b) None of the  Units  have  been  registered  under the Act or any state
securities  laws.  The Purchaser  understands  that the offering and sale of the
Units is  intended to be exempt  from  registration  under the Act, by virtue of
Section  4(2) and/or  Section 4(6) thereof and the  provisions  of  Regulation D
promulgated thereunder, based, in part, upon the representations, warranties and
agreements of the Purchaser contained in this Agreement;

      (c)  Neither  the  Securities  and  Exchange   Commission  nor  any  state
securities  commission  has  approved  the sale of the Units or the common stock
being  purchased  hereby or into which the warrants are  convertible nor has the
Commission passed upon or endorsed the merits of the Offering;

      (d) The Purchaser has had the  opportunity to obtain any  information,  to
the extent the Company had such  information  in its possession or could acquire
it without  unreasonable effort or expense,  necessary to verify the accuracy of
the  information  contained in all documents  received or reviewed in connection
with  the  purchase  of the  Units  and  has had the  opportunity  to meet  with
representatives of the Company and to have them answer any questions and provide
such  additional   information  regarding  the  terms  and  conditions  of  this
particular  investment and the finances,  operations,  business and prospects of
the Company deemed relevant by the Purchaser.

      (e) In evaluating  the  suitability  of an investment in the Company,  the
Purchaser has not relied upon any  representation  or other information (oral or
written)  other than as contained in documents so furnished to the  Purchaser by
the Company. The Purchaser and its advisors, if any, have been furnished with or
have been given access to all materials  relating to the business,  finances and
operations  of the Company and  materials  relating to the offer and sale of the
Units which have been requested by the Purchaser,  including  those set forth on
in any annex attached hereto. The Purchaser and its advisors,  if any, have been
afforded the  opportunity to ask questions of the Company and its management and
have received complete and satisfactory answers to any such inquiries;

      (f) The  Purchaser  is unaware  of, is in no way  relying  on, and did not
become aware of the Offering of the Units through or as a result of, any form of
general solicitation or general advertising including,  without limitation,  any
article,  notice,   advertisement  or  other  communications  published  in  any
newspaper,  magazine or similar media or broadcast over  television or radio, in
connection with the Offering and is not subscribing for Units and did not become
aware of the  Offering  as a result  of any  seminar  or  meeting  to which  the
Purchaser was invited by, or any solicitation of a subscription by, a person not
previously known to the Purchaser;

      (g) The  Purchaser  has taken no action which would give rise to any claim
by any person for brokerage  commissions,  finders' fees or the like relating to
this Agreement or the transactions contemplated hereby;

      (h) The Purchaser has  sufficient  knowledge and  experience in financial,
tax, and business matters, and, in particular,  investments in securities, so as
to enable the  Purchaser  to  utilize  the  information  made  available  to the
Purchaser to evaluate the merits and risks of an  investment in the Units and to
make an informed investment decision with respect thereto;

       (i) The  Purchaser is acquiring  the Units solely for his own account for
investment and not with a view to resale or distribution thereof, in whole or in
part. The Purchaser has no agreement or  arrangement,  formal or informal,  with
any person to sell or transfer all or any part of the Units purchased hereunder,
and the Purchaser has no plans to enter into any such agreement or arrangement;

      (j)  The  Purchaser  must  bear  the  substantial  economic  risks  of the
investment in the Units indefinitely  because none of the securities included in
the Units may be sold, hypothecated or otherwise disposed of unless subsequently
registered  under the Act and applicable  state  securities laws or an exemption
from such registration is available.  The Purchaser acknowledges and understands
legends shall be placed on the  certificates  representing  the shares of common
stock into which the warrants are  convertible  to the effect that they have not
been registered under the Act or applicable  state securities laws.  Appropriate
notations  thereof  will be  made  on the  securities  issued  substantially  as
follows:

                                                                               2
<PAGE>

      "THE SECURITIES  EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES  ACT OF 1933,  AS  AMENDED  (THE  "ACT"),  AND MAY NOT BE
      TRANSFERRED  EXCEPT PURSUANT TO AN EFFECTIVE  REGISTRATION UNDER THE
      ACT OR IN A TRANSACTION  WHICH, IN THE OPINION OF COUNSEL REASONABLY
      SATISFACTORY  TO THE  COMPANY,  QUALIFIES  AS AN EXEMPT  TRANSACTION
      UNDER THE ACT AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER."

      (k) In addition,  the  certificates  representing  the common stock of the
Company, and any and all securities issued in replacement thereof or in exchange
therefore,  shall bear such legend as may be required by the securities  laws of
the jurisdiction in which Purchaser resides.

      (l) The  Purchaser  has adequate  means of providing  for the  purchaser's
current  financial  needs  and  foreseeable  contingencies  and has no need  for
liquidity of the investment in the Units for an indefinite period of time;

      (m) The Purchaser:  (i) if a natural person represents that he has reached
the age of 21 and has full power and  authority  to  execute  and  deliver  this
Agreement and all other related  agreements or certificates and to carry out the
provisions  hereof and  thereof and has  adequate  means for  providing  for his
current  financial  needs and  anticipated  future needs and  possible  personal
contingencies and emergencies and has no need for liquidity in the investment in
the Units;  (ii) if a corporation,  partnership,  limited  liability  company or
partnership,   association,   joint   stock   company,   trust,   unincorporated
organization  or other  entity  represents  that such entity is duly  organized,
validly  existing  and in good  standing  under  the  laws of the  state  of its
organization,  the  consummation  of the  transactions  contemplated  hereby  is
authorized by, and will not result in a violation of state law or its charter or
other  organizational  documents,  such entity has full power and  authority  to
execute  and  deliver  this  Agreement  and  all  other  related  agreements  or
certificates and to carry out the provisions  hereof and thereof and to purchase
and hold the securities  constituting  the Units,  the execution and delivery of
this Agreement has been duly authorized by all necessary action,  this Agreement
has been duly  executed  and  delivered on behalf of such entity and is a legal,
valid  and  binding  obligation  of such  entity;  and (iii) if  executing  this
Agreement in a representative or fiduciary capacity, represents that it has full
power and  authority to execute and deliver this  Agreement in such capacity and
on behalf of the  subscribing  individual,  ward,  partnership,  trust,  estate,
corporation,  limited liability company or partnership, or other entity has full
right and power to perform  pursuant to this Agreement and make an investment in
the Company,  and that this  Agreement  constitutes  a legal,  valid and binding
obligation of such entity. The execution and delivery of this Agreement will not
violate or be in conflict  with any order,  judgment,  injunction,  agreement or
controlling document to which the Purchaser is a party or by which it is bound;

      (n) Any  information  which the  Purchaser  has  heretofore  furnished  or
furnishes  herewith to the Company is complete  and  accurate  and may be relied
upon by the  Company  in  determining  the  availability  of an  exemption  from
registration  under federal and state  securities  laws in  connection  with the
offering of the Units. The Purchaser further represents,  warrants and covenants
that it will notify and supply corrective information to the Company immediately
upon the  occurrence  of any change  therein  occurring  prior to the  Company's
issuance of the Units;

      (o) The  Purchaser  acknowledges  that the  Company is in the  development
stage,  has been  engaged in  business  for only a short  period of time and has
limited   operations.   The   Purchaser  is   knowledgeable   about   investment
considerations  in   development-stage   companies.   The  Purchaser's   overall
commitment to investments  which are not readily  marketable is not excessive in
view of the Purchaser's net worth and financial  circumstances  and the purchase
of the Units will not cause such commitment to become excessive.  The investment
in the Units is suitable one for the Purchaser;

      (p) Within three days after  receipt of a request  from the  Company,  the
Purchaser  will  provide  such  information  and deliver  such  documents as may
reasonably be necessary to comply with any and all laws and  ordinances to which
the Company or the selected dealers is subject; and

      (q) The Purchaser agrees that it may not sell, transfer, pledge, encumber,
hypothecate,  permit to be subject to a security interest, grant an option in or
otherwise dispose of the Units being acquired  hereunder or the shares of Common
Stock into which the warrants are to be convertible  unless such  securities are
registered under the Securities Act or unless an opinion of counsel satisfactory
is delivered to the Company that no such  registration  is required is delivered
to the Company;

4.  Representations  and Warranties of the Company.  The Company  represents and
warrants to the Purchaser as follows:

                                                                               3
<PAGE>

      4.1 Organization and Authority; Subsidiaries. The Company is a corporation
validly  existing and in good standing  under the laws of the State of Delaware,
with full power and  authority to enter into and perform this  Agreement and the
other agreements contemplated hereby to which it is a party. The Company is duly
licensed or  qualified  to do business as a foreign  corporation  and is in good
standing under the laws of all other jurisdictions in which the character of the
properties  owned or leased by it  therein  or in which the  transaction  of its
business makes such  qualification  necessary,  except for  jurisdictions  where
failure to become  licensed or to so qualify could not reasonably be expected to
have a material  adverse  effect on the business and  operations  of the Company
taken as a whole. The Company has all requisite corporate power and authority to
own its properties, to carry on its business as now conducted, and to enter into
and perform its obligations under this Agreement.

      4.2  Authorization;  Binding  Effect.  The Company has taken all corporate
actions which are necessary to authorize the execution, delivery and performance
of this Agreement and the consummation of the transactions contemplated hereby.

      4.3 No Bankruptcy or  Insolvency.  The Company has not filed any voluntary
petition in  bankruptcy or been  adjudicated  a bankrupt or insolvent,  filed by
petition  or answer  seeking any  reorganization,  liquidation,  dissolution  or
similar relief under any federal bankruptcy,  insolvency, or other debtor relief
law, or sought or consented to or acquiesced in the  appointment of any trustee,
receiver,  conservator  or  liquidator  of all or any  substantial  part  of its
properties. No court of competent jurisdiction has entered an order, judgment or
decree   approving  a  petition   filed   against   the   Company   seeking  any
reorganization, arrangement, composition, readjustment, liquidation, dissolution
or similar relief under any federal  bankruptcy act, or other debtor relief law,
and no other  liquidator  has been  appointed  of the  Company  or of all or any
substantial part of its properties.

      4.4 No Litigation.  There are no actions, suits or proceedings of any type
pending or, to the  knowledge  of the Company,  threatened,  against the Company
which if  adversely  determined  could  have a  material  adverse  effect on the
business and operations of the Company taken as a whole.

      4.5 Investment  Company.  The Company is not, and is not controlled by, an
"Investment Company" within the meaning of the Investment Company Act.

      4.6   Governmental   Consents  and  Notices.   No  consent,   approval  or
authorization  of or  designation,  declaration or filing with any  governmental
authority  on the part of the Company is required in  connection  with the valid
execution and delivery of this Agreement,  or the offer, sale or issuance of the
Units, or the consummation of any other transaction  contemplated hereby, except
qualification  (or taking such action as may be necessary to secure an exemption
from  qualification,  if  available)  of the offer  and sale of the Units  under
applicable state and federal  securities laws, which  qualification if required,
will be accomplished in a timely manner.

      4.7  Finders/Placement  Agents.  The Company may retain the  services of a
placement  agent(s) who may receive a placement  fee not  exceeding  ten percent
(10%) and a 3% non accountable  expense allowance.  from the gross proceeds from
this Offering.

      4.8 Units and Common  Stock.  The Units and Common  Stock,  into which the
warrants are convertible, when issued, will be duly authorized,  validly issued,
fully paid and nonassessable.

      4.9 Ownership. The Company,  through its wholly-owned  subsidiary,  is the
sole and exclusive  owner of the patents  referenced in the business plan of the
Company, and that the same have not been hypothecated or otherwise encumbered by
the Company.

      4.10  Intellectual  Property  Rights and  Interests.  The  Company has not
received any written or oral notice or claim that the Company is infringing  the
intellectual  property  rights of any other  person or legal  entity or that the
Company is in material breach or default of any license  granting to the Company
rights in any intellectual  property.  To the knowledge of the Company as of the
date hereof, without having conducted any independent  investigation or analysis
of its  intellectual  property  rights and the use thereof by third parties,  no
third party is infringing upon any intellectual  property rights  proprietary to
the Company.

5. Indemnification.  (a) The Purchaser agrees to indemnify and hold harmless the
Company, and its officers,  directors,  employees,  agents,  control persons and
affiliates  against all  losses,  liabilities,  claims,  damages,  and  expenses
whatsoever  (including,  but not  limited to, any and all  expenses  incurred in
investigating,  preparing,  or  defending  against any  litigation  commenced or
threatened)   based  upon  or  arising  out  of  any  actual  or  alleged  false
representation or warranty, or misrepresentation or omission to state a material
fact,  or breach by the  Purchaser  of any  covenant  or  agreement  made by the
Purchaser  herein or in any other  document  delivered in  connection  with this
Agreement.

                                                                               4
<PAGE>

      (b) The Company agrees to indemnify and hold harmless the  Purchaser,  and
its officers,  directors,  employees,  agents,  control  persons and  affiliates
against  all losses,  liabilities,  claims,  damages,  and  expenses  whatsoever
(including,  but not limited to, any and all expenses incurred in investigating,
preparing,  or defending  against any litigation  commenced or threatened) based
upon or arising out of any actual or alleged false  representation  or warranty,
or  misrepresentation  or  omission to state a material  fact,  or breach by the
Company of any covenant or agreement  made by the Company herein or in any other
document delivered in connection with this Agreement.

6.  Registration  Rights.  In  consideration of the purchase of the Units by the
Purchaser  described in this Agreement,  the Company will register the shares of
common stock underlying the Warrants by filing a registration statement with the
Commission within 90 days from the final closing of the Offering with respect to
the resale by the Purchaser of the shares of Common Stock issuable upon exercise
of the Warrant.

7. Lock-Up.  As an inducement to the Company to enter into this  Agreement,  the
Purchaser  agrees  to  certain  restrictions  on the  sale  or  transfer  of any
securities  being  purchased  herein.  The Purchaser will sign a lock-up whereby
Purchaser may sale up to 10% of their  holdings in the first 90 day period after
the effective  date of the  registration  statement and  thereafter up to 20% of
their  holdings in each  subsequent 90 day period.  The lock up shall expire one
year after the effective date of the registration statement. The Purchaser shall
cause each  Principal (as defined  therein) to sign and deliver to the Company a
lock-up agreement in the form attached hereto as Exhibit "C".

8. Irrevocability;  Binding Effect. The Purchaser hereby acknowledges and agrees
that the  subscription  hereunder is  irrevocable  by the  Purchaser,  except as
required by applicable  law, and that this Agreement  shall survive the death or
disability  of the  Purchaser and shall be binding upon and inure to the benefit
of the parties and their heirs,  executors,  administrators,  successors,  legal
representatives,  and  permitted  assigns.  If the  Purchaser  is more  than one
person,  the  obligations of the Purchaser  hereunder shall be joint and several
and the agreements,  representations,  warranties,  and  acknowledgments  herein
shall be deemed to be made by and be  binding  upon  each such  person  and such
person's heirs, executors,  administrators,  successors,  legal representatives,
and permitted assigns.

9. Amendment.  This Agreement shall not be amended, modified or waived except by
an  instrument in writing  signed by the party against whom any such  amendment,
modification or waiver is sought.

10. Notices. Any notice or other communication required or permitted to be given
hereunder shall be in writing

(a) if to Company, at the address set forth above,

with a copy to:

                  Aboudi & Brounstein
                  Attn: David Aboudi, Esq.
                  Rechov Gavish 3, POB 2432
                  Kfar Saba Industrial Zone 44641 Israel
                  Telephone No.: (011-972-9) 764-4833
                  Telecopier No.: (011-972-9) 764-4834

                  David@a-blaw.com

(b) if to the Purchaser,

at the address set forth on the signature page hereof

with a copy of all such communications being sent to the escrow agent,

11.  Assignability.  This  Agreement and the rights,  interests and  obligations
hereunder are not transferable or assignable by the Purchaser.

                                                                               5
<PAGE>

12.  Applicable  Law.  This  Agreement  shall be  governed by and  construed  in
accordance  with  the  laws of the  State  of New  York  without  regard  to its
conflicts of laws principles.  The Purchaser hereby  irrevocably  submits to the
jurisdiction of any United States district court located in the City of New York
over any action or proceeding arising out of or relating to this Agreement.  The
Purchaser  further  agrees  that any action or  proceeding  brought  against the
Company shall be brought only in the United States  district  courts  located in
the City of New York.

13. Use of Pronouns.  All pronouns and any variations  thereof used herein shall
be deemed to refer to the masculine, feminine, neuter, singular or plural as the
identity of the person or persons referred to may require.

14. Confidentiality.  The Purchaser acknowledges and agrees that any information
or  data  it  has  obtained  from  or  about  the  Company,  including,  without
limitation,  the business  plan of the Company,  not  otherwise  properly in the
public domain, was received in confidence.  The Purchaser agrees not to divulge,
communicate or disclose, except as may be required by law or for the performance
of this Agreement,  or use to the detriment of the Company or for the benefit of
any other person or persons, or misuse in any way, any confidential  information
of the Company,  including any scientific,  technical, trade or business secrets
of the Company and any scientific,  technical,  trade or business materials that
are treated by the Company as confidential or  proprietary,  including,  but not
limited  to,  ideas,  discoveries,  inventions,  developments  and  improvements
belonging to the Company and  confidential  information  obtained by or given to
the Company about or belonging to third parties.

15. Miscellaneous.

      (a) This Agreement  constitutes the entire agreement between the Purchaser
and the Company  with respect to the subject  matter  hereof and  supersede  all
prior oral or written  agreements and  understandings,  if any,  relating to the
subject matter hereof. The terms and provisions of this Agreement may be waived,
or consent  for the  departure  therefrom  granted,  only by a written  document
executed by the party entitled to the benefits of such terms or provisions.

      a. The Purchaser's  representations  and warranties made in this Agreement
shall survive the execution and delivery hereof and delivery of the Units to the
Purchaser.

      b.  Each  of the  parties  hereto  shall  pay its own  fees  and  expenses
(including the fees of any attorneys, accountants,  appraisers or others engaged
by  such  party)  in  connection  with  this  Agreement  and  the   transactions
contemplated  hereby  whether or not the  transactions  contemplated  hereby are
consummated.

      c. This  Agreement  may be  executed in one or more  counterparts  each of
which shall be deemed an original,  but all of which shall  together  constitute
one and the same instrument.

      d. Each provision of this Agreement  shall be considered  separable and if
for any reason any provision or provisions  hereof are  determined to be invalid
or contrary to applicable  law, such  invalidity or illegality  shall not impair
the operation of or affect the remaining portions of this Agreement.

      e.  Paragraph  titles  are for  descriptive  purposes  only and  shall not
control or alter the meaning of this Agreement as set forth in the text.

                      Accredited Investor Certification and Questionnaire

                         (Check the appropriate box(es))

1. Please check the appropriate box.

____  (i) I am a natural person who had individual  income of more than $200,000
      in each of the most  recent  two years or joint  income  with my spouse in
      excess of  $300,000  in each of the most  recent two years and  reasonably
      expect to reach that same income level for the current year ("income", for
      purposes hereof, should be computed as follows:  individual adjusted gross
      income,  as reported (or to be  reported) on a federal  income tax return,
      increased by (1) any  deduction of long-term  capital  gains under Section
      1202 of the Internal Revenue Code of 1986 (the "Code"),  (2) any deduction
      for depletion under Section 611 et seq. of the Code, (3) any exclusion for
      interest under Section 103 of the Code and (4) any losses of a partnership
      as reported on Schedule E of From 1040);

                                                                               6
<PAGE>

____  (ii) I am a natural person whose individual net worth (i.e.,  total assets
      in excess of total  liabilities),  or joint net worth with my spouse, will
      at the  time of  purchase  of the  Units  described  in this  subscription
      agreement  to  which  this  certification  is  attached  be in  excess  of
      $1,000,000;

____  (iii) The Purchaser is an investor  satisfying the requirements of Section
      501(a)(1),  (2) or (3) of  Regulation D promulgated  under the  Securities
      Act,  which  includes  but is not  limited  to, a  self-directed  employee
      benefit plan where investment decisions are made solely by persons who are
      "accredited investors" as otherwise defined in Regulation D;

____  (iv) The  Purchaser is a trust,  which trust has total assets in excess of
      $5,000,000,  which is not formed for the specific purpose of acquiring the
      Units  offered  hereby and whose  purchase is directed by a  sophisticated
      person as described in Rule  506(b)(ii)  of  Regulation D and who has such
      knowledge  and  experience  in financial  and business  matters that he is
      capable of evaluating the risks and merits of an investment in the Units;

____  (v)   I am a director or executive officer of the Company; or

____  (vi) The  Purchaser is an entity  (other than a trust) in which all of the
      equity  owners  meet  the  requirements  of at  least  one  of  the  above
      subparagraphs.

      The undersigned agrees that the undersigned will notify the Company at any
time on or prior to the  Closing  in the  event  that  the  representations  and
warranties in this Accredited  Investor  Certification and  Questionnaire  shall
cease to be true, accurate and complete.

(2)   Suitability (please answer each question)

a)    For an individual, please describe any college or graduate degrees held by
      you:

b)    For all  subscribers,  please state whether you have you  participated  in
      other private placements before:

                  YES                   NO
                            -------           -------

      (c) If your  answer  to  question  (b) above was  "YES",  please  indicate
frequency of such prior participation in private placements of:

                        Public                  Private
                        Companies               Companies
                        ----------------------- -----------------------

      Frequently        ----------------------- -----------------------
      Occasionally      ----------------------- -----------------------
      Never             ----------------------- -----------------------

      (d) For  individuals,  do you  expect  your  current  level of  income  to
significantly decrease in the foreseeable future?

                  YES                   NO
                            -------           -------

      (e) For trust, corporate, partnership and other institutional subscribers,
do you expect your total  assets to  significantly  decrease in the  foreseeable
future?

                  YES                   NO
                            -------           -------

      (f) For all  subscribers,  are you familiar  with the risk aspects and the
non-liquidity  of  investments  such as the  Securities  for  which  you seek to
purchase?

                  YES                   NO
                            -------           -------

                                                                               7
<PAGE>

      (g) For all  subscribers,  do you understand that there is no guarantee of
financial  return on this  investment  and that you run the risk of losing  your
entire investment?

                  YES                   NO
                            -------           -------

(3)   Manner in which title is to be held: (circle one)

      (a)   Individual Ownership

      (b)   Community Property

      (c)   Joint Tenant with Right of Survivorship (both parties must sign)

      (d)   Partnership

      (e)   Tenants in Common

      (f)   Company

      (g)   Trust

      (h)   Other

(4)   NASD Affiliation.

            Are you  affiliated or  associated  with an NASD member firm (please
            check one):

            YES                                NO
                    --------                          --------

            If Yes, please describe:

            ---------------------------------------------------------
            ---------------------------------------------------------
            ---------------------------------------------------------

            *If  subscriber is a Registered  Representative  with an NASD member
            firm,  have the following  acknowledgment  signed by the appropriate
            party:

            The undersigned NASD member firm acknowledges  receipt of the notice
            required by the NASD Conduct Rules.

            ---------------------------------
            Name of NASD Member Firm

            By:
                ------------------------------
                  Authorized Officer

            Date:
                  ----------------------------

      The  undersigned  is  informed of the  significance  to the Company of the
foregoing  representations and answers contained in this Purchaser Questionnaire
and such answers have been provided under the  assumption  that the Company will
rely on them.

         [Remainder of page intentionally blank, signature pages follow]

                                                                               8
<PAGE>

      IN WITNESS  WHEREOF,  the Purchaser has executed this  Agreement this ____
day of ____________ , 2005.

---------------------

(Loan - Purchase Price)

If the Purchaser is an INDIVIDUAL,  or if purchased as JOINT TENANTS, as TENANTS
IN COMMON, or as COMMUNITY PROPERTY:

----------------------------              ------------------------------

Print Name(s)                                   Social Security Number(s)

----------------------------              ------------------------------

Signature(s) of Purchaser(s)

----------------------------              ------------------------------

Date                                      Address

If the Purchaser is a PARTNERSHIP,  CORPORATION,  LIMITED  LIABILITY  COMPANY or
TRUST:

----------------------------              ------------------------------

Name of Partnership, Corporation                Federal Taxpayer

Limited Liability Company or Trust              Identification Number

----------------------------

Date

By:
   -------------------------              ------------------------------

     Name:                                State of Organization

    Title:                                ------------------------------

                                          ------------------------------

                                     Address

SUBSCRIPTION ACCEPTED AND AGREED TO

this ____ day of ________________, 2005.

SPO MEDICAL  INC.

By:
   ----------------------------
     Name:  Michael Braunold

     Title: CEO

                                                                               9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]